• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.88% Nasdaq Up 0.69%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    1.15 Down 0.02(1.43%) 11:44AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.17
    Open:1.20
    Bid:1.18 x 3300
    Ask:1.19 x 300
    1y Target Est:2.04
    Beta:1.96492
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:1.15 - 1.22
    52wk Range:0.84 - 7.78
    Volume:138,713
    Avg Vol (3m):2,294,240
    Market Cap:87.04M
    P/E (ttm):N/A
    EPS (ttm):-0.59
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNSS

    Comparison

    Symbol% ChgMkt Cap
    SNSSDown 1.43%87.04M
    PFEUp 0.88%198.90B
    AZNUp 2.15%81.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.50
    Quarterly EPS Est (Sep-15) :-0.13
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):-0.02

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback